Current Report Filing (8-k)
21 Agosto 2018 - 7:04AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d)
OF
THE SECURITIES EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported): August 16, 2018
Health
Insurance Innovations, Inc.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
001-35811
|
|
46-1282634
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
15438
N. Florida Avenue, Suite 201
Tampa,
Florida
|
|
33613
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code: (813) 397-1187
Not
Applicable
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company [X]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item
1.02. Termination of a Material Definitive Agreement.
The
information in Item 5.02 is incorporated herein by reference.
Item
5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
of Certain Officers.
On
August 16, 2018, Health Insurance Innovations, Inc. (the “Company”) announced a transition in the leadership of its
HealthPocket, Inc. subsidiary. As a part of this transition, Mr. Bruce Telkamp, the CEO of HealthPocket and of the Company’s
Consumer Division, and Dr. Sheldon Wang, the Company’s Chief Technology Officer, will cease to be employed by the Company
as of August 17, 2018. Also as a part of this transition, the Employment Agreement for each of Mr. Telkamp and Dr. Wang was terminated
by the Company “without cause” on August 16, 2018, which entitles each of Mr. Telkamp and Dr. Wang to severance compensation
in the form of 12 months of base salary continuation under the terms of such Employment Agreements so long as they execute a general
release in favor of the Company. In addition, subject to the delivery of general releases, the Company agreed to the vesting of
Mr. Telkamp and Dr. Wang’s unvested restricted shares previously granted under the Company’s Long-Term Incentive Plan.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
HEALTH INSURANCE INNOVATIONS, INC.
|
|
|
|
|
By:
|
/s/
Michael D. Hershberger
|
|
Name:
|
Michael
D. Hershberger
|
|
Title:
|
Chief
Financial Officer
|
Date:
August 20, 2018
Health Insurance Innovat... (NASDAQ:HIIQ)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Health Insurance Innovat... (NASDAQ:HIIQ)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024
Notícias em tempo-real sobre Health Insurance Innovations Inc da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Health Insurance Innovations, Inc.